Literature DB >> 12065196

Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine.

Rui Tao1, Anne Fray, Sue Aspley, Richard Brammer, David Heal, Sidney Auerbach.   

Abstract

Hypothalamic 5-HT (serotonin) regulates food intake, energy expenditure and bodyweight. Using in vivo microdialysis, we determined the effects of various anorectic drugs on hypothalamic extracellular 5-HT levels during the dark phase when rats predominantly feed. Phentermine and aminorex, which were originally considered to be catecholaminergic drugs, markedly increased 5-HT efflux in rat hypothalamus. Their actions were less profound than D-fenfluramine, but considerably greater than that of the selective 5-HT reuptake inhibitor, fluoxetine. This suggests that enhanced hypothalamic 5-HT function could be involved in their anorectic actions. Pharmacological characterization revealed that D-fenfluramine, aminorex and probably also phentermine potentiate synaptic 5-HT function predominantly by release, whereas fluoxetine acts exclusively by reuptake inhibition. The results also revealed that the combined actions of phentermine and D-fenfluramine on hypothalamic extracellular 5-HT levels were additive, but not synergistic. In contrast, there was a significant negative cooperative effect on extraneuronal 5-HT of combining phentermine with fluoxetine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065196     DOI: 10.1016/s0014-2999(02)01751-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  21 in total

1.  Fluoxetine prevents 8-OH-DPAT-induced hyperphagia in Fischer inbred rats.

Authors:  Chandra Suma Johnson Miryala; Navin Maswood; Lynda Uphouse
Journal:  Pharmacol Biochem Behav       Date:  2011-01-28       Impact factor: 3.533

Review 2.  Central nervous system biogenic amine targets for control of appetite and energy expenditure.

Authors:  David L Nelson; Donald R Gehlert
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 3.  Appetite suppressants, cardiac valve disease and combination pharmacotherapy.

Authors:  Richard B Rothman; Michael H Baumann
Journal:  Am J Ther       Date:  2009 Jul-Aug       Impact factor: 2.688

4.  Comparison of female Fischer and Sprague-Dawley rats in the response to ketanserin.

Authors:  Chandra Suma Johnson Miryala; Cindy Hiegel; Lynda Uphouse
Journal:  Pharmacol Biochem Behav       Date:  2013-11-04       Impact factor: 3.533

Review 5.  Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans.

Authors:  M A van Gestel; E Kostrzewa; R A H Adan; S K Janhunen
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

6.  Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.

Authors:  Jutatip Guptarak; Jhimly Sarkar; Cindy Hiegel; Lynda Uphouse
Journal:  Horm Behav       Date:  2010-03-08       Impact factor: 3.587

7.  Hypothesis: Neuroendocrine Mechanisms (Hypothalamus-Growth Hormone-STAT5 Axis) Contribute to Sex Bias in Pulmonary Hypertension.

Authors:  Pravin B Sehgal; Yang-Ming Yang; Edmund J Miller
Journal:  Mol Med       Date:  2015-07-30       Impact factor: 6.354

8.  Adolescent male rats are less sensitive than adults to the anxiogenic and serotonin-releasing effects of fenfluramine.

Authors:  Andrew E Arrant; Hikma Jemal; Cynthia M Kuhn
Journal:  Neuropharmacology       Date:  2012-10-24       Impact factor: 5.250

Review 9.  STAT5a/b contribute to sex bias in vascular disease: A neuroendocrine perspective.

Authors:  Pravin B Sehgal; Yang-Ming Yang; Huijuan Yuan; Edmund J Miller
Journal:  JAKSTAT       Date:  2015-09-18

Review 10.  Serotonergic drugs and valvular heart disease.

Authors:  Richard B Rothman; Michael H Baumann
Journal:  Expert Opin Drug Saf       Date:  2009-05       Impact factor: 4.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.